AZN vs MG · P/E 28, $288.38B cap vs P/E 18, rev $362.2M
AstraZeneca PLC (AZN) versus Mistras Group Inc (MG) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Mistras Group Inc (MG) is a security & protection services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported MG revenue for 2026-06-30 was $362.2M. Net income was $10.0M. MG currently screens at market cap $258.5M and trailing P/E 17.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MG currently screens at market cap $258.5M and trailing P/E 17.7.
Not investment advice. Open the AZN and MG stock pages for the full models.
Not investment advice.